The growth is by private equity sponsor Great Point Partners. Cytovance is based in Oklahoma City and is a contract manufacturing organization of mammalian and microbial biologics. Cytovance supports customers from clinical development to commercial launch in domestic and international markets.
In June, Monroe Capital received funding for $15.5 million senior secured credit facility to support the acquisition of Employee Benefit Solutions by Pharos Capital Group.
More articles on surgery centers:
5 tips for avoiding wrong-site surgery
Creating a healthy ASC culture: 8 perspectives
7 bright ideas for ASC administrators today (and every day)
